Article Details

CymaBay Therapeutics (NASDAQ:CBAY) Downgraded by BidaskClub

Retrieved on: 2020-12-10 06:11:15

Tags for this article:

Click the tags to see associated articles and topics

CymaBay Therapeutics (NASDAQ:CBAY) Downgraded by BidaskClub. View article details on hiswai:

Excerpt

<b>Schonfeld Strategic Advisors</b> LLC now owns 501,368 shares of the biopharmaceutical company's stock valued at $3,630,000 after purchasing an ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up